Position in TMO
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$41,886,121
-$6,374,752 QoQ
Shares Held
83,545
-14.9% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
1.33%
of 13F equity value
Holder Rank
#311
of 2,606 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Covea Finance holds $55,749,908 across 3 Diagnostics & Research names. TMO ranks #1 (75.1% of the industry book) .
All Filings in TMO
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $41,886,121 | 83,545 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $48,260,873 | 98,185 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $55,926,775 | 96,517 | Shares | Sole | 2026-01-07 | |
| 2025-09-30 | $46,812,675 | 96,517 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $41,013,900 | 101,154 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $51,309,526 | 103,114 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $51,607,336 | 99,201 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $64,709,226 | 104,611 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $49,278,383 | 89,111 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $49,293,001 | 84,811 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $36,683,427 | 69,111 | Shares | Sole | 2024-01-08 | |
| 2023-09-30 | $32,704,149 | 64,611 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $28,268,936 | 54,181 | Shares | Sole | 2023-07-07 | |
| 2023-03-31 | $42,774,723 | 74,214 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $44,534,300 | 80,870 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $42,309,789 | 83,420 | Shares | Sole | 2022-10-27 | |
| No filing history on record for this holder in this stock. | ||||||